Seeking Alpha

EP Vantage » Articles » FVRL |

More on FVRL by EP Vantage
Articles by Ticker

Latest Comments on EP Vantage's Articles

  1. sierranvin on High Hopes Remain for Celgene's Revlimid: yeah, like your one patient anecdote adds something to a... more »
  2. daphne doesn't believe on High Hopes Remain for Celgene's Revlimid: yeah, my sister ended up in the emergency room in february with a... more »
  3. Vobogeck on Merck KGaA: Another Stumble Leaves Investors Worried: Merck KGaA, which trades on the DAX, is an unrelated entity to... more »
  4. Pierr Johnson on Genzyme's Very Bad Year: Kudos for the insights. Still, it is important to point out the... more »
  5. frosty on Genzyme's Very Bad Year: Mr. Icahn is interested only in turning a fast buck. People like... more »
  6. San Juan on Genzyme's Very Bad Year: The article highlights all the known information that has produced... more »
  7. Justin M. Hall on Genzyme's Very Bad Year: Regarding Icahn, check out Biogen Idec (BIIB) mid-2007. As I... more »
  8. stockinvestor on Genzyme's Very Bad Year: I agree with the facts that you provide in your article, but I... more »
  9. InvestmentGuru on Poniard Pharmaceuticals' Gamble Doesn't Pay Off: CEO JM is a gambler and should be put behind bars for not... more »
  10. Justin M. Hall on NeurogesX: Next Stop, U.S. Market: EP: Thank you for the heads up on NGSX. Justin more »
  11. jay brebner on Poniard Pharmaceuticals' Gamble Doesn't Pay Off: spear was a very risky trial given the way it was designed. their... more »
  12. northernerx on Direction of Cholesterol Debate Could Benefit Abbott Labs: There are (at least) two components of HDL. Niaspan raises levels... more »
  13. psusense on Hemispherx Biopharma: Investors Growing Tired of CFS Drug Delays: HEB has always been about confusion. They were even trying to jump... more »
  14. vinthetoolman on Hemispherx Biopharma: Investors Growing Tired of CFS Drug Delays: A fresh angle to know what he means when he writes.. By Adam... more »
  15. rgard32 on Hemispherx Biopharma: Investors Growing Tired of CFS Drug Delays: Wheres the CRL? rofl.....the fda wont give heb a crl until the nda... more »